Venus Remedies Ltd Overview
Fundamentals of Venus Remedies Ltd
|P/E Ratio (TTM)||11.3|
|Debt to Equity||0.09|
Financials of Venus Remedies Ltd
|Jun 2022||Sep 2022||Dec 2022||Mar 2023|
|Profit before tax||7.89||5.77||4.54||19.73|
|EPS in Rs||5.16||3.99||2.46||8.27|
About Venus Remedies Ltd
Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudh ... ary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as 'WHO-GMP' as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc. In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox. Read More
|Stocks||Market Cap (cr)||Market Price (₹)||52 Week Low-High (₹)|
|Supriya Lifescience Ltd||₹2,063.58||
|246.15 - 260|
|Celestial Biolabs Ltd||₹4.56||
|1.75 - 1.8|
|JFL Life Sciences Ltd||₹46.85||
|40 - 42|
|Procter & Gamble Health Ltd||₹8,421.43||
|4954 - 5092.25|
|Veerhealth Care Ltd||₹31.40||
|26 - 26|
What is the Share price of Venus Remedies Ltd (VENUSREM)?
Can I buy Venus Remedies Ltd (VENUSREM) shares?
How do I buy Venus Remedies Ltd (VENUSREM) from Angel One?
- Direct investment: You can buy Venus Remedies Ltd (VENUSREM) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Venus Remedies Ltd (VENUSREM) shares.